Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer

Lauren Chiec, Ami N. Shah*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science